About Contact Us Careers

Osteoarthritis Gene Therapy Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4083
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Osteoarthritis Gene Therapy Landscape

Sanofi-aventis Groupe
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Horizon Therapeutics plc
Hanmi Pharm. Co., Ltd.
ALMATICA PHARMA LLC.
Assertio Holdings, Inc.
Flexion Therapeutic, Inc.
Zimmer Biomet Holdings, Inc.
Pfizer Inc.
Virchow Biotech Privet Limited
Bayer AG

Browse Key Market Insights with Data Illustration:

Osteoarthritis Gene Therapy Market Size & Share, Growth Report 2037

In the News

April 27, 2022: Horizon Therapeutic plc acquires the fifth rank among top companies for overall corporate reputation in the annual survey of PatientView.
April 26, 2022: Sanofi makes the announcement about merging path with McLaren Racing to boost the manufacturing quantity and its excellence standards on a world-class level.

Author Credits: Radhika Pawar

Report ID: 4083
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of osteoarthritis gene therapy is estimated at USD 8.61 billion.

Osteoarthritis Gene Therapy Market size was valued at USD 8.07 billion in 2024 and is likely to cross USD 21.68 billion by 2037, expanding at more than 7.9% CAGR during the forecast period i.e., between 2025-2037.

Europe industry is estimated to dominate majority revenue share by 2037, on the back of increasing geriatric population with osteoarthritis disease.

The major players in the market are Sanofi-aventis Groupe, Horizon Therapeutics plc, Hanmi Pharm. Co., Ltd., ALMATICA PHARMA LLC., Assertio Holdings, Inc., Flexion Therapeutic, Inc., Zimmer Biomet Holdings, Inc., Pfizer Inc., and others.

Inquiry Before Buying Request Free Sample